Neogenomics Inc
Change company Symbol lookup
Select an option...
NEO Neogenomics Inc
PRTK Paratek Pharmaceuticals Inc
EGRAY Energy Resources Of Australia Ltd
IVAC Intevac Inc
AMPX Amprius Technologies Inc
PFE Pfizer Inc
BNOX Bionomics Ltd
CRKN Crown Electrokinetics Corp.
CAE CAE Inc
YMAB Y-mAbs Therapeutics Inc
Go

Health Care : Health Care Providers & Services | Small Cap Blend
Company profile

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories. The Company operates through two segments: the Clinical Services Segment and the Pharma Services Segment. The Clinical Services segment provides various clinical testing services to community-based pathology practices, oncology practices, hospital pathology labs, reference labs, and academic centers with reimbursement from various payers, including client direct billing, commercial insurance, Medicare and other government payers, and patients. The Pharma Services segment supports pharmaceutical firms in their drug development programs by providing testing services and data analytics for clinical trials and research. The Company offers testing services, which include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, immunohistochemistry (IHC) and digital imaging, molecular testing and morphologic analysis. It operates testing laboratories in United States, Europe and Asia.

Closing Price
$17.41
Day's Change
-0.20 (-1.14%)
Bid
--
Ask
--
B/A Size
--
Day's High
18.11
Day's Low
17.29
Volume
(Heavy Day)
Volume:
1,696,681

10-day average volume:
1,382,561
1,696,681
  • Prev Close
    17.61
  • Today's Open
    17.71
  • Day's Range
    17.29-18.11
  • Avg Vol (10-day)
    1.4M
  • Last (time)
    3:59p ET 03/31/23
  • Last (size)
    3
  • 52-Wk Range
    6.00 - 19.51
    LowHigh
  • (10/24/22 - 03/16/23)
    10.76%
  • 84.6%
  • Market Cap
    2.2B
  • Shares Outstanding
    127.5M
  • -1.16
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.1
  • 88.38
  • (% of float 03/15/23)
    5.27

Latest News

March 27, 2023
7:00 am ET
Accesswire
March 22, 2023
8:00 am ET
BusinessWire
March 17, 2023
5:00 pm ET
Globe Newswire
March 16, 2023
7:00 am ET
Accesswire
March 13, 2023
7:00 am ET
Accesswire
February 28, 2023
7:00 am ET
Accesswire
February 24, 2023
6:04 am ET
MarketWatch
February 23, 2023
7:01 am ET
Accesswire
February 21, 2023
9:20 am ET
Globe Newswire
February 06, 2023
10:00 am ET
Globe Newswire
7:00 am ET
Accesswire
7:00 am ET
Accesswire
February 05, 2023
9:00 pm ET
Accesswire
10:06 am ET
Accesswire
February 04, 2023
10:03 pm ET
Accesswire
10:32 am ET
Accesswire
February 03, 2023
10:50 pm ET
BusinessWire
9:00 pm ET
Globe Newswire
9:00 pm ET
BusinessWire
1:00 pm ET
BusinessWire
10:46 am ET
Accesswire
February 02, 2023
10:51 pm ET
Accesswire
February 01, 2023
11:03 am ET
Accesswire
11:00 am ET
Globe Newswire
6:27 am ET
MarketWatch
1:45 am ET
PR Newswire
January 31, 2023
10:51 pm ET
Globe Newswire
4:55 pm ET
Accesswire
4:30 pm ET
Accesswire
11:01 am ET
Accesswire
1:45 am ET
Globe Newswire
January 30, 2023
11:15 pm ET
Accesswire
2:15 pm ET
Globe Newswire
10:00 am ET
Globe Newswire
6:02 am ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.